Precision medicine's blind spot: Rebalancing the evidence base to reflect women's health

Bird CE, Al Ibrahim H
Science advances · 2026 · vol. 12(24) , pp. eaei0515 · doi:10.1126/sciadv.aei0515 · PMID:42268963 · PMC13251823
Review OA: gold CC-BY-NC-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-07 ⓘ

This paper argues that precision medicine requires an evidence base reflecting women's biology, advocating for reforms in funding, study design, and sex-disaggregated reporting to better address women's health conditions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Precision medicine requires an evidence base that reflects women's biology, demanding reforms in funding, study design, and sex-disaggregated reporting.

My notes (saved in your browser only)

MeSH descriptors

Evidence-Based Medicine Precision Medicine Precision Medicine Women's Health Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

SciLite annotations

organisms 2
noordeloos 2009062 noordeloos 2009062

Source provenance

europepmc
last seen: 2026-11-08T09:52:27.483963+00:00
pubmed
last seen: 2026-10-08T21:55:40.749282+00:00
scilite
last seen: 2026-08-16T09:53:34.102730+00:00
unpaywall
last seen: 2026-08-14T06:25:32.811723+00:00
License: CC-BY-NC-4.0